PMC3267537_01
Spectral domain optical coherence tomography (A), fluorescein angiogram (B), and spectral domain optical coherence tomography thickness map (C) of the left eye prior to treatment with difluprednate.
opth-6-155f1.jpg
PMC3267537_01_opth-6-155f1.jpg
f1-opth-6-155
SD-OCT revealed CME with intraretinal thickening and a central macular thickness of 819 mum (0.64 mm3) in her left eye (Figure 1A and C). Fundus fluorescein angiography confirmed severe CME in the late phase of the angiogram (Figure 1B).
Spectral domain optical coherence tomography (A), fluorescein angiogram (B), and spectral domain optical coherence tomography thickness map (C) of the left eye after treatment with difluprednate.
opth-6-155f2.jpg
PMC3267537_01_opth-6-155f2.jpg
f2-opth-6-155
SD-OCT imaging showed complete resolution of CME with a central macular thickness of 310 (0.24 mm3, Figure 2A and C) Repeat fundus fluorescein angiography showed resolution of CME (Figure 2B).